Cambridge Investment Research Advisors’s Synaptics SYNA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SYNA Stock Details SYNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$460K	Sell	3,703 -12,666	-77%	-$1.43M	﹤0.01%	3045
2026 Q1	$1.15M	Buy	+16,369	New	+$1.33M	﹤0.01%	2047
2022 Q2	–	Sell	-1,722	Closed	-$344K	–	3203
2022 Q1	$344K	Sell	1,722 -384	-18%	-$85.2K	﹤0.01%	2429
2021 Q4	$610K	Sell	2,106 -1,291	-38%	-$308K	﹤0.01%	1948
2021 Q3	$611K	Sell	3,397 -248	-7%	-$41.7K	﹤0.01%	1893
2021 Q2	$567K	Sell	3,645 -280	-7%	-$37.9K	﹤0.01%	1949
2021 Q1	$532K	Sell	3,925 -169	-4%	-$20.6K	﹤0.01%	1864
2020 Q4	$395K	Buy	4,094 +990	+32%	+$80.6K	﹤0.01%	1933
2020 Q3	$250K	Buy	+3,104	New	+$245K	﹤0.01%	2078
2014 Q1	–	Sell	-5,648	Closed	-$293K	–	1339
2013 Q4	$293K	Buy	+5,648	New	+$277K	0.01%	895

Other funds holding SYNA

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Cambridge Investment Research Advisors's SYNA Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Synaptics (SYNA) stake by 77% in Q2 2026, selling an estimated $1.43M and leaving 3,703 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #3045.

Cambridge Investment Research Advisors first reported a position in SYNA in Q4 2013 and has held it in 10 quarters since. The position peaked at $1.15M in Q1 2026. 375 funds tracked by Wall St. Rank hold SYNA as of Q2 2026.

Cambridge Investment Research Advisors held 3,703 shares of Synaptics worth $460K as of Q2 2026.
Cambridge Investment Research Advisors sold 12,666 Synaptics shares in Q2 2026, an estimated $1.43M.
Synaptics made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3045 holding.
Cambridge Investment Research Advisors first reported a position in Synaptics in Q4 2013 and has held it in 10 quarters since.
Cambridge Investment Research Advisors's Synaptics position peaked at $1.15M in Q1 2026.
375 funds tracked by Wall St. Rank held Synaptics as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.